Genomic medicine holds promise as a potential important novel tool in primary care. However, the current evidence basis regarding pharmogenetics and genetic risk estimates and the trade-off between benefits and harm of introducing genomic medicine in present day primary care is low. More research into this new area is warranted. Also training of general practitioners in correct use and interpretation of genetic testing is needed to ensure successful implementation.